DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it will expand its footprint in Asia-Pacific with the opening of an office in Manila, Philippines. This announcement follows the recent expansion of ICON’s operations in Seoul, Korea and ICON Central Laboratories’ move to a larger laboratory facility in Singapore.
